IE
RPTP

Israel Englander’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Israel Englander’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,362,118
Closed -$7.32M – 3931
2016
Q2 		$7.32M Sell
1,362,118
-1,121,175
-45% -$5.75M 0.02% 1027
2016
Q1 		$11.4M Buy
2,483,293
+353,919
+17% +$1.42M 0.03% 746
2015
Q4 		$11.1M Buy
2,129,374
+1,429,350
+204% +$8.29M 0.02% 874
2015
Q3 		$4.24M Sell
700,024
-80,175
-10% -$982K 0.01% 1430
2015
Q2 		$12.3M Sell
780,199
-76,519
-9% -$929K 0.02% 855
2015
Q1 		$9.31M Buy
856,718
+395,543
+86% +$4.04M 0.02% 1052
2014
Q4 		$4.85M Buy
461,175
+347,367
+305% +$3.39M 0.01% 1409
2014
Q3 		$1.09M Buy
113,808
+73,335
+181% +$749K ﹤0.01% 2244
2014
Q2 		$467K Buy
+40,473
New +$369K ﹤0.01% 2625
2014
Q1 		– Sell
-491,355
Closed -$6.4M – 4327
2013
Q4 		$6.4M Buy
491,355
+478,225
+3,642% +$6.59M 0.02% 985
2013
Q3 		$196K Buy
+13,130
New +$157K ﹤0.01% 3113

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return

Israel Englander's RPTP Position: Q3 2016 in Review

Israel Englander sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 1,362,118 shares — an estimated $7.32M sold.

Israel Englander first reported a position in RPTP in Q3 2013 and held it in 11 quarters. The position peaked at $12.3M in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Israel Englander reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Israel Englander sold 1,362,118 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $7.32M.
  • Israel Englander first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 11 quarters.
  • Israel Englander's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $12.3M in Q2 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Millennium Management's 13F filing for Q3 2016, filed 14 Nov 2016.